TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) Free cash flow 2016–2022
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$1.0BFY2022 · since FY2016: $3.0B → $1.0B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $1.0B | +341.5% |
| FY2021 | $236.0M | -63.0% |
| FY2020 | $638.0M | +186.1% |
| FY2019 | $223.0M | -87.6% |
| FY2018 | $1.8B | +32.9% |
| FY2017 | $1.4B | -54.8% |
| FY2016 | $3.0B | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice